Cite
HARVARD Citation
Polewski, M. et al. (2022). A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone. Applied immunohistochemistry & molecular morphology. 30 (4), pp. 237-245. [Online].